-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Singular Genomics Systems (NASDAQ:OMIC) Stock Price Up 2%
Singular Genomics Systems (NASDAQ:OMIC) Stock Price Up 2%
Singular Genomics Systems, Inc. (NASDAQ:OMIC – Get Rating)'s share price rose 2% during trading on Tuesday . The company traded as high as $2.12 and last traded at $2.05. Approximately 73,542 shares were traded during trading, a decline of 47% from the average daily volume of 138,934 shares. The stock had previously closed at $2.01.
Analysts Set New Price Targets
Separately, The Goldman Sachs Group decreased their target price on Singular Genomics Systems from $3.50 to $3.00 and set a "neutral" rating for the company in a report on Tuesday, November 8th.
Get Singular Genomics Systems alerts:Singular Genomics Systems Stock Performance
The firm has a 50-day moving average of $2.15 and a two-hundred day moving average of $2.89. The company has a quick ratio of 19.00, a current ratio of 20.18 and a debt-to-equity ratio of 0.04. The company has a market capitalization of $146.36 million, a PE ratio of -1.64 and a beta of 0.84.
Singular Genomics Systems (NASDAQ:OMIC – Get Rating) last announced its quarterly earnings results on Monday, November 7th. The company reported ($0.33) earnings per share for the quarter, beating the consensus estimate of ($0.37) by $0.04. Research analysts anticipate that Singular Genomics Systems, Inc. will post -1.37 EPS for the current year.Insider Activity at Singular Genomics Systems
In related news, insider Eli N. Glezer purchased 50,000 shares of Singular Genomics Systems stock in a transaction that occurred on Monday, December 12th. The stock was bought at an average cost of $2.00 per share, for a total transaction of $100,000.00. Following the completion of the transaction, the insider now owns 4,185,000 shares in the company, valued at $8,370,000. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 22.60% of the stock is owned by company insiders.
Institutional Trading of Singular Genomics Systems
A number of institutional investors and hedge funds have recently made changes to their positions in the business. Bank of New York Mellon Corp increased its position in shares of Singular Genomics Systems by 12.5% in the third quarter. Bank of New York Mellon Corp now owns 149,558 shares of the company's stock valued at $374,000 after buying an additional 16,636 shares in the last quarter. EP Wealth Advisors LLC purchased a new stake in shares of Singular Genomics Systems in the third quarter valued at approximately $26,000. Balyasny Asset Management LLC purchased a new stake in shares of Singular Genomics Systems in the third quarter valued at approximately $26,000. State Street Corp increased its position in shares of Singular Genomics Systems by 9.1% in the third quarter. State Street Corp now owns 811,015 shares of the company's stock valued at $2,028,000 after buying an additional 67,455 shares in the last quarter. Finally, Platinum Investment Management Ltd. increased its position in shares of Singular Genomics Systems by 105.2% in the third quarter. Platinum Investment Management Ltd. now owns 881,068 shares of the company's stock valued at $2,203,000 after buying an additional 451,732 shares in the last quarter. 56.33% of the stock is currently owned by hedge funds and other institutional investors.
About Singular Genomics Systems
(Get Rating)
Singular Genomics Systems, Inc, a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits.
Featured Stories
- Get a free copy of the StockNews.com research report on Singular Genomics Systems (OMIC)
- Is First Solar Stock is Flying Too Close to the Sun?
- What's the Outlook for META Stock in 2023?
- Can Investors Cash In On PayPal?
- These 3 Tech Stocks Are in for a Happier New Year
- Tyson Foods: Growth and Momentum at a Reasonable Price
Receive News & Ratings for Singular Genomics Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Singular Genomics Systems and related companies with MarketBeat.com's FREE daily email newsletter.
納斯達克股價週二上漲2%,盤中一度漲至2.12美元,最新報2.05美元。當日成交量約為73,542股,較日均成交量138,934股下降47%。此前該股收盤價為2.01美元。
分析師設定新的價格目標
另外,高盛夫婦在11月8日星期二的一份報告中將他們對奇異基因組系統公司的目標價從3.50美元下調至3.00美元,並將該公司的評級定為“中性”。
到達奇異基因組學系統警報:奇異基因組學系統股票表現
該公司的50日移動均線切入位在2.15美元,200日移動均線切入位在2.89美元。該公司的速動比率為19.00,流動比率為20.18,債務權益比率為0.04。該公司市值為1.4636億美元,本益比為-1.64,貝塔係數為0.84。
奇異基因組系統公司(納斯達克代碼:OMIC-GET Rating)上一次公佈季度收益是在11月7日(星期一)。該公司公佈了本季度每股收益(0.33美元),比普遍預期的(0.37美元)高出0.04美元。研究分析師預計,單基因系統公司本年度的每股收益將達到1.37美元。單一基因組學系統公司的內部活動
在相關新聞中,內部人士伊萊·N·格雷澤在12月12日星期一的一筆交易中購買了50,000股奇異基因系統公司的股票。這只股票是以每股2.00美元的平均價格購買的,總交易額為100,000.00美元。交易完成後,這位內部人士現在擁有該公司418.5萬股股份,價值837萬美元。此次收購是在提交給美國證券交易委員會的一份檔案中披露的,該檔案可在美國證券交易委員會網站。22.60%的股份由公司內部人士持有。
單一基因組系統的制度性交易
一些機構投資者和對沖基金最近改變了他們在該業務中的頭寸。紐約梅隆銀行(Bank Of New York Mellon Corp)第三季度將其在Single Genome Systems的股票頭寸增加了12.5%。紐約梅隆銀行(Bank Of New York Mellon Corp)目前持有149,558股該公司股票,價值374,000美元,此前該公司在上一季度又購買了16,636股。EP Wealth Advisors LLC在第三季度購買了Single Genome Systems的新股份,價值約2.6萬美元。Balyasny Asset Management LLC在第三季度購買了Single Genome Systems的新股份,價值約2.6萬美元。道富集團在第三季度將其在Single Genome Systems的股票頭寸增加了9.1%。道富銀行目前持有811,015股該公司股票,價值2,028,000美元,上一季度又購買了67,455股。最後,鉑金投資管理有限公司在第三季度將其在Single Genome Systems的持股比例提高了105.2%。鉑金投資管理有限公司目前持有881,068股該公司股票,價值2,203,000美元,該公司在上個季度又購買了451,732股。56.33%的股票目前由對沖基金和其他機構投資者持有。
關於奇異基因組學系統
(獲取評級)
單一基因組系統公司是一家生命科學技術公司,開發下一代測序和多組學技術,為研究人員和臨床醫生製造產品,促進科學和醫學的發展。該公司製造G4儀器,一種臺式下一代測序儀,用於產生基因測序結果,以及相關的消耗品套裝菜單。
專題報道
- 免費獲取StockNews.com關於奇異基因組系統(OMIC)的研究報告
- 第一太陽能股票是不是飛得離太陽太近了?
- 2023年元股票的前景如何?
- 投資者能從PayPal中獲利嗎?
- 這三隻科技股將迎來一個更快樂的新年
- 泰森食品:合理價格的增長和動力
《奇異基因組學系統日報》獲得新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊,接收最新新聞的每日簡明摘要和分析師對Single Genome Systems及相關公司的評級。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧